AUTH:"Ju ZZ" - Search results

Search results

1-5 of 5 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

<sup>18</sup>F-Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies.
Tang G, Lu JY, Li XY, Yao RX, Yang YJ, Jiao FY, Chen MJ, Liang XN, Ju ZZ, Ge JJ, Zhao YX, Shen B, Wu P, Sun YM, Wu JJ, Yen TC, Zuo C, Wang J, Zhao QH, [...] Shanghai Memory Study (SMS) and Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)
Mov Disord, 18 Nov 2024
Cited by: 0 articles | PMID: 39555939
Add to export list
¹⁸ F-Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal Syndrome.
Liu FT, Lu JY, Li XY, Jiao FY, Chen MJ, Yao RX, Liang XN, Ju ZZ, Ge JJ, Li G, Shen B, Wu P, Song J, Li J, Sun YM, Wu JJ, Yen TC, Luo JF, Zhao QH, [...] Progressive Supranuclear Palsy Neuroimage Initiative
Mov Disord, 38(4):579-588, 07 Feb 2023
Cited by: 7 articles | PMID: 36750757
Add to export list
The Monoamine Oxidase-B Inhibitor Selegiline Does Not Affect ¹⁸ F-Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series.
Li XY, Jiao FY, Yao RX, Ju ZZ, Chen MJ, Ge JJ, Li G, Sun YM, Wu P, Wu JJ, Yen TC, Zuo C, Wang J, Lu JY, Liu FT, Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)
Mov Disord, 38(4):705-707, 27 Jan 2023
Cited by: 1 article | PMID: 36707403
Add to export list
¹⁸ F-Florzolotau Tau Positron Emission Tomography Imaging in Patients with Multiple System Atrophy-Parkinsonian Subtype.
Liu FT, Li XY, Lu JY, Wu P, Li L, Liang XN, Ju ZZ, Jiao FY, Chen MJ, Ge JJ, Sun YM, Wu JJ, Yen TC, Luo JF, Zuo C, Wang J, Progressive Supranuclear Palsy Neuroimage Initiative (PSPNI)
Mov Disord, 37(9):1915-1923, 21 Jul 2022
Cited by: 9 articles | PMID: 35861378
Add to export list
In Vivo ¹⁸ F-APN-1607 Tau Positron Emission Tomography Imaging in MAPT Mutations: Cross-Sectional and Longitudinal Findings.
Zhou XY, Lu JY, Liu FT, Wu P, Zhao J, Ju ZZ, Tang YL, Shi QY, Lin HM, Wu JJ, Yen TC, Zuo CT, Sun YM, Wang J
Mov Disord, 37(3):525-534, 29 Nov 2021
Cited by: 5 articles | PMID: 34842301
Add to export list

1-5 of 5 results

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

<sup>18</sup>F-Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies.

¹⁸ F-Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal Syndrome.

The Monoamine Oxidase-B Inhibitor Selegiline Does Not Affect ¹⁸ F-Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series.

¹⁸ F-Florzolotau Tau Positron Emission Tomography Imaging in Patients with Multiple System Atrophy-Parkinsonian Subtype.

In Vivo ¹⁸ F-APN-1607 Tau Positron Emission Tomography Imaging in MAPT Mutations: Cross-Sectional and Longitudinal Findings.

Partnerships & funding

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

<sup>18</sup>F-Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies.

18 F-Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal Syndrome.

The Monoamine Oxidase-B Inhibitor Selegiline Does Not Affect 18 F-Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series.

18 F-Florzolotau Tau Positron Emission Tomography Imaging in Patients with Multiple System Atrophy-Parkinsonian Subtype.

In Vivo 18 F-APN-1607 Tau Positron Emission Tomography Imaging in MAPT Mutations: Cross-Sectional and Longitudinal Findings.

Partnerships & funding

¹⁸ F-Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal Syndrome.

The Monoamine Oxidase-B Inhibitor Selegiline Does Not Affect ¹⁸ F-Florzolotau Uptake in Patients with Progressive Supranuclear Palsy: A Longitudinal Case Series.

¹⁸ F-Florzolotau Tau Positron Emission Tomography Imaging in Patients with Multiple System Atrophy-Parkinsonian Subtype.

In Vivo ¹⁸ F-APN-1607 Tau Positron Emission Tomography Imaging in MAPT Mutations: Cross-Sectional and Longitudinal Findings.